Trial Profile
Clinical research of CLENAFIN
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2021
Price :
$35
*
At a glance
- Drugs Efinaconazole (Primary)
- Indications Onychomycosis; Tinea unguium
- Focus Therapeutic Use
- Sponsors Kaken Pharmaceutical
- 01 Oct 2021 Results of a retrospective analysis of 82 subjects with longitudinal spikes, assessed the efficacy of 10% efinaconazole solution in the treatment of onychomycosis with longitudinal spikes published in the Journal of Dermatology
- 26 Mar 2019 Status changed from active, no longer recruiting to completed.
- 03 Jul 2017 Status changed from recruiting to active, no longer recruiting.